Springer NatureBrowse
12967_2016_774_MOESM1_ESM.tif (48.95 kB)
Download file

MOESM1 of Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction

Download (48.95 kB)
figure
posted on 2016-01-20, 05:00 authored by Roseanne Raphael, Diana Purushotham, Courtney Gastonguay, Marla Chesnik, Wai-Meng Kwok, Hsiang-En Wu, Sanjiv Shah, Shama Mirza, Jennifer Strande
Additional file 1: Figure S1.  Flow cytometry to assess platelet activation. Purified platelet samples were incubated with fluorescently labeled antibodies against CD62P and CD41 and subject to flow cytometry. Platelets positive for CD41 + but negative for CD62P are non-activated. CD62P positive platelets are activated.

Funding

Clinical and Translational Science Award (CTSI) program of the National Center for Research Resources, National Institutes of Health

History

Usage metrics

Read the peer-reviewed publication

Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction
Journal of Translational MedicineJournal of Translational Medicine

Categories

Keywords

Platelet proteomeHeart failure with preserved ejection fractionInflammationS100A8Induced pluripotent stem cell-derived cardiomyocytes

Licence

CC BY + CC0

Exports